mPEG-r-crisantaspase
AZPO2-CLT-001
Phase 1 mab completed
Quick answer
mPEG-r-crisantaspase for Hematologic Malignancies is a Phase 1 program (mab) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Hematologic Malignancies
- Phase
- Phase 1
- Modality
- mab
- Status
- completed